Adjuvant Global Health Technology Fund – AN2 Therapeutics, Melioidosis & Tuberculosis Therapeutic (Epetraborole) Global Health Agreement Post author:GHIAA Admin Post published:August 26, 2024 Post category: Continue ReadingAdjuvant Global Health Technology Fund – AN2 Therapeutics, Melioidosis & Tuberculosis Therapeutic (Epetraborole) Global Health Agreement
Gates Foundation – BioNTech, TB & HIV Product Strategic Letter Agreement Post author:GHIAA Admin Post published:July 15, 2024 Post category: Continue ReadingGates Foundation – BioNTech, TB & HIV Product Strategic Letter Agreement
MPP – Gates Medical Research Institute, TB therapeutic (Sutezolid) Sublicense Agreement Post author:GHIAA Admin Post published:May 30, 2024 Post category: Continue ReadingMPP – Gates Medical Research Institute, TB therapeutic (Sutezolid) Sublicense Agreement
India Department of Biotechnology (DBT), Memorandum of Agreement Post author:GHIAA Admin Post published:April 8, 2024 Post category: Continue ReadingIndia Department of Biotechnology (DBT), Memorandum of Agreement
Wellcome Trust Standard Grant Terms & Conditions Post author:GHIAA Admin Post published:February 19, 2024 Post category: Continue ReadingWellcome Trust Standard Grant Terms & Conditions
UK Medical Research Council – Indevus Pharmaceuticals, Antiviral Microbicide, Collaborative Research and Licensing Agreement Post author:GHIAA Admin Post published:December 20, 2023 Post category: Continue ReadingUK Medical Research Council – Indevus Pharmaceuticals, Antiviral Microbicide, Collaborative Research and Licensing Agreement
UC Berkeley, Therapeutics & Diagnostics, Exclusive License Agreement Template Post author:GHIAA Admin Post published:November 30, 2023 Post category: Continue ReadingUC Berkeley, Therapeutics & Diagnostics, Exclusive License Agreement Template
GARDP – Orchid Pharma Ltd., Cefiderocol Manufacturing Sublicense and Technology Transfer Agreement Post author:GHIAA Admin Post published:November 15, 2023 Post category: Continue ReadingGARDP – Orchid Pharma Ltd., Cefiderocol Manufacturing Sublicense and Technology Transfer Agreement
Gates Foundation – Visterra, Strategic Relationship Letter Agreement Post author:GHIAA Admin Post published:September 19, 2023 Post category: Continue ReadingGates Foundation – Visterra, Strategic Relationship Letter Agreement